Expert Review of Pharmacoeconomics and Outcomes Research, 1473-7167

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. 2018
  3. Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)

    Florian Wagenlehner, Björn Wullt, Stefania Ballarini, Daniel Zingg & Kurt G. Naber, 2018, I : Expert Review of Pharmacoeconomics and Outcomes Research. 18, 1, s. 107-117

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2017
  5. Transposition and implementation of EU rare disease policy in Eastern Europe

    Ana V Pejcic, Georgi Iskrov, Ralitsa Raycheva, Rumen Stefanov & Mihajlo Michael Jakovljevic, 2017 dec, I : Expert Review of Pharmacoeconomics & Outcomes Research. 17, 6, s. 557-566 10 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  6. 2016
  7. Life expectancy and health expenditure evolution in Eastern Europe-DiD and DEA analysis

    Mihajlo B Jakovljevic, Mira Vukovic & John Fontanesi, 2016 aug, I : Expert Review of Pharmacoeconomics & Outcomes Research. 16, 4, s. 537-46

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Advantages and disadvantages of discrete-event simulation for health economic analyses.

    J Jaime Caro & Jörgen Möller, 2016, I : Expert Review of Pharmacoeconomics & Outcomes Research.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2015
  10. Evolution of the Serbian pharmaceutical market alongside socioeconomic transition

    Mihajlo B Jakovljevic, Natasa Djordjevic, Milena Jurisevic & Slobodan Jankovic, 2015 jun, I : Expert Review of Pharmacoeconomics & Outcomes Research. 15, 3, s. 521-30

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2014
  12. 10th World IHEA and ECHE Joint Congress: health economics in the age of longevity

    Mihajlo B Jakovljevic, Thomas E Getzen, Aleksandra Torbica & Tomofumi Anegawa, 2014 dec, I : Expert Review of Pharmacoeconomics & Outcomes Research. 14, 6, s. 781-783

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  13. Contemporary generic market in Japan - key conditions to successful evolution

    Mihajlo B Jakovljevic, Sanae Nakazono & Seiritsu Ogura, 2014 apr, I : Expert Review of Pharmacoeconomics & Outcomes Research. 14, 2, s. 181-94 14 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  14. 2010
  15. Health, happiness, inequality

    Martin Karlsson, Therese Nilsson & Carl Hampus Lyttkens, 2010, I : Expert Review of Pharmacoeconomics & Outcomes Research. 10, 1, s. 497-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2008
  17. Social capital, social class and tobacco smoking

    Martin Lindström, 2008, I : Expert Review of Pharmacoeconomics and Outcomes Research. 8, 1, s. 81-89 9 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  18. 2005
  19. Feasibility and linguistic validity of the Swedish version of the PDQ-39

    Peter Hagell, 2005, I : Expert Review of Pharmacoeconomics & Outcomes Research. 5, 2, s. 131-136

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2004
  21. Changes in drug spending for different age groups during the 1990s? Evidence from Sweden

    Ulf Gerdtham & Douglas Lundin, 2004, I : Expert Review of Pharmacoeconomics and Outcomes Research. 4, 3, s. 343-351 19 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift